SE8602524D0 - Novel quinoline derivatives, pharmaceutical compositions containing them and process for the preparation thereof - Google Patents
Novel quinoline derivatives, pharmaceutical compositions containing them and process for the preparation thereofInfo
- Publication number
- SE8602524D0 SE8602524D0 SE8602524A SE8602524A SE8602524D0 SE 8602524 D0 SE8602524 D0 SE 8602524D0 SE 8602524 A SE8602524 A SE 8602524A SE 8602524 A SE8602524 A SE 8602524A SE 8602524 D0 SE8602524 D0 SE 8602524D0
- Authority
- SE
- Sweden
- Prior art keywords
- lower alkyl
- quinoline derivatives
- stands
- general formula
- image
- Prior art date
Links
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title abstract 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical class N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000002373 5 membered heterocyclic group Chemical group 0.000 abstract 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
- 230000000637 radiosensitizating effect Effects 0.000 abstract 1
- 238000001959 radiotherapy Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU852193A HU195487B (en) | 1985-06-04 | 1985-06-04 | Process for producing quinoline derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8602524D0 true SE8602524D0 (sv) | 1986-06-04 |
| SE8602524L SE8602524L (sv) | 1986-12-05 |
| SE466308B SE466308B (sv) | 1992-01-27 |
Family
ID=10958222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8602524A SE466308B (sv) | 1985-06-04 | 1986-06-04 | Kinolinderivat |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US4652562A (sv) |
| JP (1) | JPS6248668A (sv) |
| KR (1) | KR930006775B1 (sv) |
| CN (1) | CN1012957B (sv) |
| AT (1) | AT392469B (sv) |
| AU (1) | AU588883B2 (sv) |
| BE (1) | BE904864A (sv) |
| CA (1) | CA1266650A (sv) |
| CH (1) | CH668069A5 (sv) |
| CS (1) | CS257793B2 (sv) |
| DD (1) | DD247448A5 (sv) |
| DE (1) | DE3618724C2 (sv) |
| DK (1) | DK162841C (sv) |
| ES (1) | ES8707231A1 (sv) |
| FI (1) | FI82451C (sv) |
| FR (1) | FR2582835B1 (sv) |
| GB (1) | GB2176185B (sv) |
| GR (1) | GR861452B (sv) |
| HU (1) | HU195487B (sv) |
| IL (1) | IL79024A0 (sv) |
| IT (1) | IT1204377B (sv) |
| NL (1) | NL8601434A (sv) |
| NO (1) | NO165635C (sv) |
| PH (1) | PH24135A (sv) |
| PL (1) | PL146498B1 (sv) |
| PT (1) | PT82712B (sv) |
| SE (1) | SE466308B (sv) |
| SU (1) | SU1398773A3 (sv) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6331286B1 (en) | 1998-12-21 | 2001-12-18 | Photogen, Inc. | Methods for high energy phototherapeutics |
| US8974363B2 (en) * | 1997-12-11 | 2015-03-10 | Provectus Pharmatech, Inc. | Topical medicaments and methods for photodynamic treatment of disease |
| US20090117199A1 (en) * | 1998-08-06 | 2009-05-07 | Scott Timothy C | Method of treatment of cancer |
| US8557298B2 (en) * | 1998-08-06 | 2013-10-15 | Provectus Pharmatech, Inc. | Medicaments for chemotherapeutic treatment of disease |
| US7384623B1 (en) | 1998-12-21 | 2008-06-10 | Provectus Pharmatech, Inc. | High energy phototherapeutic agents |
| US8470296B2 (en) * | 1998-12-21 | 2013-06-25 | Provectus Pharmatech, Inc. | Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| US20020001567A1 (en) * | 1998-12-21 | 2002-01-03 | Photogen, Inc. | Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| EP1320529B1 (en) * | 2000-09-21 | 2006-05-24 | Smithkline Beecham Plc | Quinoline derivatives as antibacterials |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU165520B (sv) * | 1972-05-05 | 1974-09-28 | ||
| IE47458B1 (en) * | 1977-11-07 | 1984-03-21 | Leo Pharm Prod Ltd | Quinolylguanidine derivatives |
-
1985
- 1985-06-04 HU HU852193A patent/HU195487B/hu not_active IP Right Cessation
-
1986
- 1986-05-28 CH CH2153/86A patent/CH668069A5/de not_active IP Right Cessation
- 1986-05-30 DD DD86290766A patent/DD247448A5/de not_active IP Right Cessation
- 1986-06-03 PH PH33848A patent/PH24135A/en unknown
- 1986-06-03 BE BE0/216734A patent/BE904864A/fr not_active IP Right Cessation
- 1986-06-03 KR KR1019860004409A patent/KR930006775B1/ko not_active Expired - Fee Related
- 1986-06-03 AT AT1492/86A patent/AT392469B/de not_active IP Right Cessation
- 1986-06-03 CN CN86103688A patent/CN1012957B/zh not_active Expired
- 1986-06-04 CA CA000510779A patent/CA1266650A/en not_active Expired - Lifetime
- 1986-06-04 AU AU58344/86A patent/AU588883B2/en not_active Ceased
- 1986-06-04 IL IL79024A patent/IL79024A0/xx not_active IP Right Cessation
- 1986-06-04 ES ES555708A patent/ES8707231A1/es not_active Expired
- 1986-06-04 PT PT82712A patent/PT82712B/pt unknown
- 1986-06-04 US US06/870,396 patent/US4652562A/en not_active Expired - Fee Related
- 1986-06-04 DK DK262186A patent/DK162841C/da not_active IP Right Cessation
- 1986-06-04 GB GB08613530A patent/GB2176185B/en not_active Expired
- 1986-06-04 NO NO862230A patent/NO165635C/no unknown
- 1986-06-04 PL PL1986259871A patent/PL146498B1/pl unknown
- 1986-06-04 FR FR8608039A patent/FR2582835B1/fr not_active Expired
- 1986-06-04 FI FI862381A patent/FI82451C/sv not_active IP Right Cessation
- 1986-06-04 JP JP61130006A patent/JPS6248668A/ja active Granted
- 1986-06-04 DE DE3618724A patent/DE3618724C2/de not_active Expired - Fee Related
- 1986-06-04 GR GR861452A patent/GR861452B/el unknown
- 1986-06-04 IT IT20667/86A patent/IT1204377B/it active
- 1986-06-04 SE SE8602524A patent/SE466308B/sv not_active IP Right Cessation
- 1986-06-04 SU SU864027590A patent/SU1398773A3/ru active
- 1986-06-04 CS CS864112A patent/CS257793B2/cs unknown
- 1986-06-04 NL NL8601434A patent/NL8601434A/nl not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI872864A0 (sv) | Förfarande för framställning av farmaceutiskt aktiva bensimidazolföreningar | |
| NO171785C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinazolinderivater | |
| NO874454D0 (no) | Nye derivater av benzimidazoler med anti-ulcusaktivitet og fremgangsmaate for deres fremstilling. | |
| FI810604L (fi) | Foerfarande foer framstaellning av indanderivat | |
| IL57577A0 (en) | 1,2-dihydroquinolin-2-one derivatives,process for their preparation and pharmaceutical compositions containing the same | |
| GR890300125T1 (en) | Billiary acid derivatives, processes for the preparation thereof and phamaceutical compositions containing them | |
| ATE74352T1 (de) | Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen. | |
| DK519985D0 (da) | Quinoloncarboxylsyrederivater, fremgangsmaade til fremstilling deraf og antibakterielt middel indeholdende saadanne derivater | |
| ES8207180A1 (es) | Procedimiento de fabricacion de derivados de tetrahidro-5,67,7a 4h-tieno (3,2-c) piridinona-2 . | |
| SE8602524D0 (sv) | Novel quinoline derivatives, pharmaceutical compositions containing them and process for the preparation thereof | |
| IL63381A0 (en) | 5-substituted 5,10-dihydro-11h-dibenzo(b,e)(1,4)diazepin-11-one derivatives,their preparation and pharmaceutical compositions containing them | |
| DK180985D0 (da) | Cyklopentylaetere, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende saadanne aetere | |
| PT87025A (pt) | Process for the preparation of imidazol derivatives and of pharmaceutical compositions containing the same | |
| DK188183D0 (da) | Thiomethylpyridinderivater, fremgangsmade til deres fremstilling og laegemidler indeholdende disse forbindelser | |
| ATE83482T1 (de) | Piperidin-derivate, deren herstellung und deren verwendung als heilmittel. | |
| ATE123487T1 (de) | Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen. | |
| DE3677857D1 (de) | 2,5-dimethylpyrrolderivative, ihre herstellung und ihre verwendung. | |
| ATE139441T1 (de) | Verwendung von 2-iminothiazolidin-4-onderivaten als neuartige arzneimittelwirkstoffe | |
| ATE30152T1 (de) | 1-methyl-5-nitro-imidazolin-derivate und diese enthaltende therapeutische zusammensetzungen. | |
| LV5491A3 (lv) | 2-tiazolidinona atvasinajumu iegusanas panemiens | |
| DK614989D0 (da) | Indolderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem | |
| ATE78032T1 (de) | 2-pyridylessigsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| DE3365933D1 (en) | Substituted thienobenzodiazepinones, process for their preparation and medicines containing these compounds | |
| NO158462C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive (1,2)-kondenserte 1,4-benzodiazepinforbindelser. | |
| SE8703494D0 (sv) | Mellanprodukter anvendbara vid framstellning av 2-tiofen-ettiksyraderivat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8602524-4 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |
Ref document number: 8602524-4 Format of ref document f/p: F |